跳至主要内容
临床试验/CTRI/2021/07/034963
CTRI/2021/07/034963尚未招募未知

Comparison of efficacy and safety of nalbuphine, dexmedetomidine and tramadol for treatment of post-spinal shivering in pregnant women undergoing Caesarean section

Government Institute of Medical sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients from obstetrics group aged between 20â??40 years of ASA grade I and II undergoing caesarean section.2. Patients who will give a valid informed written consent.
  • 3.Patients who will develop shivering of grade 3or4.

排除标准

  • 1. Patients of age group between 20-40belonging to ASA grade III and IV.
  • 2. Patients with known hypersensitivity to tramadol, dexmedetomidine and nalbuphine.
  • 3. Patients who will not give valid informed consent.
  • 4. Patients who will have shivering before spinal anaesthesia.
  • 5. Patients who will have shivering before delivery.
  • 6. Contraindication of spinal anaesthesia.

研究者

发起方
Government Institute of Medical sciences

相似试验